Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-12-14

Clinical Trial Update: Efficacy and Tolerability of Hirudoid Cream in Prophylaxis and Treatment Infusion Phlebitis [Phase 3]

View source ↗

Summary

Phase 3 trial assessing efficacy and tolerability of Hirudoid Cream for prophylaxis and treatment of infusion phlebitis; completed study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hirudoid Cream (mucopolysaccharide polysulfate)

Snippet

Sponsor: Medinova AG | Conditions: Thrombophlebitis, Phlebitis | Phase 3 | Status: COMPLETED